Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1420-55-9

Post Buying Request

1420-55-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1420-55-9 Usage

Description

Thiethylperazine, also known as a phenothiazine derivative, is a compound characterized by the presence of a perazine molecule substituted by an ethylsulfanyl group at the 2nd position. It belongs to the class of phenothiazines, which are a group of chemical compounds that share a common tricyclic structure.

Uses

Used in Pharmaceutical Industry:
Thiethylperazine is used as a pharmaceutical agent for its potential therapeutic applications. The compound's unique structure allows it to interact with various biological targets, making it a promising candidate for the development of new drugs to treat a range of medical conditions.
Used in Research and Development:
In the field of research and development, thiethylperazine serves as a valuable compound for studying the structure-activity relationships of phenothiazines. This knowledge can be applied to design and synthesize novel phenothiazine-based drugs with improved pharmacological properties and reduced side effects.
Used in Chemical Synthesis:
Thiethylperazine can also be utilized as a starting material or intermediate in the synthesis of other phenothiazine-based compounds. Its unique ethylsulfanyl substitution at position 2 provides a distinct chemical handle for further functionalization and modification, enabling the development of new molecules with diverse applications.

Originator

Torecan,Boehringer Ingelheim,US,1961

Manufacturing Process

26.1 parts of 3-ethylmercapto-phenothiazine (melting point 95°C to 97°C), 4.7 parts of finely pulverized sodium amide and 120 parts by volume of absolute xylene are heated to boiling for two hours, under reflux and while stirring the reaction mixture, at an oil-bath temperature of 180°C. Without interrupting the heating, a solution of 20.0 parts of 1-methyl-4-(3'- chloropropyl-1')-piperazine (boiling point 95°C to 97°C at a pressure of 10 mm Hg) in 20 parts by volume of xylene is added dropwise in the course of 1 1/2 hours. After heating 3 more hours, the reaction mixture is cooled and 10.0 parts of ammonium chloride added; the mixture is then shaken out three times, using 50 parts by volume of water each time. The xylene solution is extracted with 250 parts by volume of aqueous tartaric acid of 15% strength, after which the tartaric acid extract is washed with 80 parts by volume of benzene and then rendered phenolphthalein-alkaline by the addition of 60 parts by volume of concentrated aqueous caustic soda solution. The base which precipitates is taken up in a total of 150 parts by volume of benzene; the benzene layer is dried over potassium carbonate and is then evaporated under reduced pressure. The residue from the evaporation is distilled in a high vacuum. After separating a preliminary distillate which passes over up to 226°C under a pressure of 0.01 mm Hg the main fraction - 3-ethylmercapto- 10-[3'-(1''-methyl-piperazyl-4'')-propyl-1']-phenothiazine - which distills at 226°C to 228°C under the last-mentioned pressure is collected. The analytically pure base boils at 227°C under a pressure of 0.01 mm Hg and melts at 62°C to 64°C.Upon the addition of ethanolic HCl to a solution, cooled to 0°C, of 26.38 parts of the free base in 130 parts by volume of absolute ethanol, until a Congoacid reaction is achieved, the crystalline dihydrochloride of 3-ethylmercapto- 10-[3'-(1''-methyl-piperazyl-4'')-propyl-1']phenothiazine is precipitated. The analytically pure salt has a melting point of 214°C to 216°C (bubbles); it begins to sinter at 205°C. The dimaleate melts at 188°C to 190°C after sintering from 180°C (recrystallized from methanol).

Therapeutic Function

Antiemetic

Check Digit Verification of cas no

The CAS Registry Mumber 1420-55-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,2 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1420-55:
(6*1)+(5*4)+(4*2)+(3*0)+(2*5)+(1*5)=49
49 % 10 = 9
So 1420-55-9 is a valid CAS Registry Number.
InChI:InChI=1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3

1420-55-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name thiethylperazine

1.2 Other means of identification

Product number -
Other names Ethylthioperazine.

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1420-55-9 SDS

1420-55-9Downstream Products

1420-55-9Related news

ClinicalEFFICACY OF thiethylperazine (cas 1420-55-9) AS A RECOVERY ROOM ANTI-EMETIC09/30/2019

SUMMARYOf approximately 3,500 recovery room patients, 5 per cent vomited one or more times. Either thiethylperazine or placebo was then administered in double-blind style, and both agents were approximately 60 per cent successful after one injection. However, 56 per cent of a similar series of (...detailed

An assessment of thiethylperazine (cas 1420-55-9) (Torecan) in the control of radiation-induced nausea and vomiting09/29/2019

A double-blind trial was undertaken to compare thiethylperazine (Torecan) and pyridoxine as anti-emetics in patients undergoing externally applied radiotherapy to the abdomen and pelvis. The patients who received thiethylperazine experienced fewer or much milder symptoms than those given pyridoxine.detailed

The prevention of emesis with thiethylperazine (cas 1420-55-9) following oral surgery☆09/28/2019

The results of the study presented here corroborate the findings of previous investigations that thiethylperazine is a very useful and dependable antiemetic agent. The onset of action is rapid, and no side effects or incidents of extrapyramidal reaction were observed at any time throughout the s...detailed

The metabolism of thiethylperazine (cas 1420-55-9) (torecan®)10/01/2019

The synthesis of thiethylperazine (= Torecan®) with a 35S-labelled phenothiazine ring is described. Its resorption, distribution in the organism, and its excretion in the faeces, urine and bile are investigated in the rat and compared with similar investigations for thioridazine.detailed

A comparative study of the effects of cinnarizine, sulpiride and thiethylperazine (cas 1420-55-9) on vestibular nystagmus in rabbits09/27/2019

The effects of cinnarizine, sulpiride, thiethylperazine and a placebo on vestibular nystagmus in rabbits were investigated. The nystagmus was provoked by means of a torsion swing. A suppressive effect was shown by all drugs and not by the placebo. A fast and strong effect was seen after the admi...detailed

Dystonic reactions following thiethylperazine (cas 1420-55-9) in children09/26/2019

Dystonic reactions in 30 children receiving thiethylperazine are reported. All children developed extrapyramidal symptoms following therapeutic or excess dose of the drug. All these symptoms were effectively reversed with biperidine lactate.detailed

1420-55-9Relevant articles and documents

Stability of some phenothiazine free radicals.

Levy,Tozer,Tuck,Loveland

, p. 898 - 905 (2007/10/10)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1420-55-9